Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kohn

Showing results (281-290 of 369) with videos related to

Pageof 37
Sort By:
JCO Clinical Cancer Informatics|January 18, 2019
Technology Applications: Use of Digital Health Technology to Enable Drug DevelopmentJoyce F Liu, Jung-Min Lee, Ellie Strock, et al.
Cancer|June 22, 2010
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancerChristina M Annunziata, Helene Tuft Stavnes, Lilach Kleinberg, et al.
Journal of the National Cancer Institute|January 5, 1994
Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancerE C Kohn, G Sarosy, A Bicher, et al.
International Journal of Cancer|October 9, 1996
Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell linesW J Wasilenko, A J Palad, K D Somers, et al.
Molecular Cancer Therapeutics|January 12, 2008
Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancersEllen V Stevens, Satoshi Nishizuka, Smitha Antony, et al.
Ophthalmic Plastic and Reconstructive Surgery|August 4, 2015
Prostaglandin Eyedrops Are Associated With Decreased Thicknesses of Eyelid Dermis and Orbicularis Oculi Muscle: Ultrasonographic FindingsAlice S Goh, Nariman Nassiri, Jocelyne C Kohn, et al.
Seminars in Oncology|March 31, 2004
Molecular therapeutics: promise and challengesElise C Kohn, Yiling Lu, Hongwei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulationsE C Kohn, W D Figg, G A Sarosy, et al.
Gynecologic Oncology|May 3, 2011
A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group StudyRobert S Mannel, Mark F Brady, Elise C Kohn, et al.
Cancer Biology & Therapy|November 14, 2003
BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cellsMaria Fiammetta Romano, Michelina Festa, Antonello Petrella, et al.
Pageof 37

Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
JCO Clinical Cancer Informatics|January 18, 2019
Technology Applications: Use of Digital Health Technology to Enable Drug DevelopmentJoyce F Liu, Jung-Min Lee, Ellie Strock, et al.
Cancer|June 22, 2010
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancerChristina M Annunziata, Helene Tuft Stavnes, Lilach Kleinberg, et al.
Journal of the National Cancer Institute|January 5, 1994
Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancerE C Kohn, G Sarosy, A Bicher, et al.
International Journal of Cancer|October 9, 1996
Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell linesW J Wasilenko, A J Palad, K D Somers, et al.
Molecular Cancer Therapeutics|January 12, 2008
Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancersEllen V Stevens, Satoshi Nishizuka, Smitha Antony, et al.
Ophthalmic Plastic and Reconstructive Surgery|August 4, 2015
Prostaglandin Eyedrops Are Associated With Decreased Thicknesses of Eyelid Dermis and Orbicularis Oculi Muscle: Ultrasonographic FindingsAlice S Goh, Nariman Nassiri, Jocelyne C Kohn, et al.
Seminars in Oncology|March 31, 2004
Molecular therapeutics: promise and challengesElise C Kohn, Yiling Lu, Hongwei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulationsE C Kohn, W D Figg, G A Sarosy, et al.
Gynecologic Oncology|May 3, 2011
A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group StudyRobert S Mannel, Mark F Brady, Elise C Kohn, et al.
Cancer Biology & Therapy|November 14, 2003
BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cellsMaria Fiammetta Romano, Michelina Festa, Antonello Petrella, et al.
Pageof 37